Diabetes and sarcopenia are emerging as serious public health issues. Sarcopenia, an age-
related disorder characterized by loss of skeletal muscle mass and function, is recognized …

Sarcopenia, defined as the loss of skeletal muscle mass and strength and/or a decrease in
physical performance, is classically related to aging. However, chronic disease, including …

Sarcopenia, loss of muscle mass with age, is considered as a major cause of frailty and
decreased independence in the elderly population. On the other hand, ageing is associated …

The incidence and prevalence of metabolic and musculoskeletal diseases are increasing.
Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance, inflammation …

Sarcopenia and diabetes are two age-related diseases that are common in the elderly
population, and have a serious effect on their general health and quality of life. Sarcopenia …

Sarcopenia is a geriatric syndrome characterized by decline of skeletal muscle mass and
function. Contributing factors include nutritional, genetic, inflammatory, and endocrinal …

Type 2 diabetes mellitus (T2DM) represents a major health burden for the elderly
population, affecting approximately 25% of people over the age of 65 years. This percentage …

Sarcopenia is an age-related clinical complaint characterized by the progressive
deterioration of skeletal muscle mass and strength over time. Type 2 diabetes (T2D) is …

Aims Sarcopenia generally refers to the age-related reduction in muscle strength, functional
ability, and muscle mass. Sarcopenia is a multifactorial condition associated with poor …

Diabetes prevalence is increasing rapidly in older people, and sarcopenia is prevalent as a
novel complication, particularly in patients with type 2 diabetes mellitus (T2DM). Therefore …